News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Novartis Corporation (JOBS) Says Swine Flu Shot Works with Single Dose; World-first Swine-flu Vaccine Trial Reveals One Dose Provides “Strong Immune Response”
September 3, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Novartis's vaccine against H1N1 swine flu gave a strong immune response even after one dose in a pilot trial, the Swiss drugmaker said on Thursday.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 1
MORE ON THIS TOPIC
Insights
Beyond equity: Why venture debt is reshaping European biotech
October 8, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Parkinson’s disease
Cerevance Parkinson’s drug shortens ‘off time’ in Ph. 3, paving path to FDA
October 7, 2026
·
2 min read
·
Annalee Armstrong
Lung cancer
ArriVent sheds nearly half of value on late-stage lung cancer miss
October 7, 2026
·
2 min read
·
Gabrielle Masson
Business
Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, more
October 7, 2026
·
2 min read
·
Jef Akst